-
-
-
-
-
-
-
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
-
-
-
-
-
-
-
Processa Pharmaceuticals Inc. (PCSA) CEO Issues Shareholder Letter Providing Outlook for 2022
-
-
-
-
-
-
-
Form S-1/A Processa Pharmaceuticals
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

